Compound ID | 40
Class: Antimicrobial peptide
| Spectrum of activity: | Gram-positive |
| Details of activity: | MRSA (methicillin resistant Staphylococcus aureus) and VRE (vancomycin resistant Enterococcus sp.) |
| Institute where first reported: | The University of Manchester, UK |
| Year first mentioned: | 2015 |
| Highest developmental phase: | Preclinical |
| Development status: | Experimental |